Functional characterization of novel candidate IBD genes (R. Beyaert is spokesperson of the Excellence of Science (EOS) programme “Taking IBD Genes from GWAS to Function to Drug Target” (BRIDGE))
Crosstalk between epithelial cells and immune cells in gut, skin and lung inflammation
Molecular and cellular mechanisms involved in intestinal transit and constipation (subteam I. Afonina)
Metabolic engineering of probiotic yeast for efficient delivery of anti-inflammatory metabolites to the gut (subteam J. Staal)
CBM signaling and MALT1 protease activity in inflammation, immunity and cancer
Inborn errors of immunity in chronic inflammation and immunodeficiency
Development and preclinical validation of novel cytokine antagonists
Areas of expertise: Inflammation, Immunity, Cancer